Orserdu savings card: $0 a month with commercial insurance

How to pay the least

Ask for the cash price

Orserdu

We didn’t find one.

Ask your pharmacy for Orserdu’s cash price, and one or two other pharmacies too.
Orserdu’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand nameOrserdu

Authorized genericelacestrant

Regular genericelacestrant

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Orserdu?

The original

–

Brand nameThe maker’s card

ORSERDU Co-pay Card Program

Savings card from Stemline Therapeutics (a Menarini Group company)

No insuranceNeeds insuranceNo cash price listed.

Insurance $0 a month

The card takes up to $25,000 a year off your co-pay.

Or call 1-800-519-2140.

In the maker’s words

“With this card, eligible patients will pay a $0…”

From the maker’s offer on orserducopay.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Orserdu itself, from the same company, sold without the brand name, and usually for less. For now Orserdu is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Advanced ER+, HER2- breast cancer with an ESR1 mutation, after menopause or in men

What the FDA label says

ORSERDU is an estrogen receptor antagonist indicated for:

treatment of postmenopausal women or adult men, with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer, as detected by an FDA-authorized test, with disease progression following at least one line of endocrine therapy

Source: the FDA label for Orserdu (Stemline Therapeutics, Inc.), June 24, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/orserdu/